Amneal Stock Rises 21% After Q2 Profit Beats Estimates, Raises Guidance
Shares of Amneal Pharmaceuticals, Inc. (AMRX) are rising 21 percent on Friday after turning to profit in the second quarter, compared to a loss last year and also beat estimates.